Editorial: Targeting the Immune System to Treat Hepatitis B Virus Infection.

Meng, Zhongji; Liu, Jia; Kosinska, Anna D; Lu, Mengji

Meng, Zhongji; Liu, Jia; Kosinska, Anna D; Lu, Mengji.

Afiliación

Meng Z; Institute of Biomedical Research, Hubei Clinical Research Center for Precise Diagnosis and Therapy of Liver Cancer, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Liu J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Kosinska AD; Institute of Virology, Technische Universität München/Helmholtz Zentrum München, Munich, Germany.
Lu M; German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.

Front Immunol ; 13: 868616, 2022.

Article en En | MEDLINE | ID: mdl-35371080

Palabras clave

Immune response; T cell therapy; hepatitis B Virus; immune tolerance; immunotherapy; innate immunity; therapeutic vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google